APA (7th ed.) Citation

SW, D., I, O., ED, G., HE, M., PW, M., AL, G., . . . JJ, C. (2026). Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Consensus Statement by the North American Neuro-Ophthalmology Society and the American Academy of Ophthalmology. Ophthalmology. https://doi.org/10.1016/j.ophtha.2026.04.008

Chicago Style (17th ed.) Citation

SW, DeParis, Oke I, Gaier ED, Moss HE, MacIntosh PW, Gilbert AL, Dinkin MJ, and Chen JJ. "Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Consensus Statement by the North American Neuro-Ophthalmology Society and the American Academy of Ophthalmology." Ophthalmology 2026. https://doi.org/10.1016/j.ophtha.2026.04.008.

MLA (9th ed.) Citation

SW, DeParis, et al. "Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Consensus Statement by the North American Neuro-Ophthalmology Society and the American Academy of Ophthalmology." Ophthalmology, 2026, https://doi.org/10.1016/j.ophtha.2026.04.008.